The Environment Committee’s scrutiny of secondary legislation under the 9th Legislature

by

The European Parliament’s Environment Committee is the most active Committee scrutinizing the Commission’s output of secondary legislation.

Since the 9th legislature sat for the first time on 10 July 2019, the Environment Committee has seen 70 challenges tabled.

 

Updated 8 July 2022

A review of the challenges of the Environment Committee 

10 July 2019 –

Objection to the extension of the approval periods of the active substances –flumioxazine and others

Implementing Act

Rapporteur: Anja Hazekamp (GUE/NGL)

Debate in Committee:  25 September 2019

Adopted: For 47; against: 22; abstention(s): 1. Link

Vote in Plenary: 10 October 2019

Vote: For 415, Against 252, Abstentions 2o

Votewatch link

 


 

Commission’s follow up: SP(2019)669-2019:2825

2.

Objection to the extension of the approval periods of active substances

Implementing Act

Rapporteur: Anja Hazekamp (GUE/NGL)

Debate in Committee:  25 September 2019

Adopted: For 49; Against: 20; abstention(s): 1. Link

Vote in Plenary: 10 October 2019

Vote: For 402, Against 222, Abstentions 39

Votwwatch link

Commission’s follow up:

 

SP2019:2826

 

3

Issue: Objection to GMO Maize

Implementing Act

Co-Rapporteurs: Sirpa Pietikäinen (PPE) Günther Sidl (S&D) Nicolae Ştefănuță (Renew) Tilly Metz (Verts/ALE), Anja Hazekamp (GUE/NGL) Eleonora Evi (NI)

Debate in Committee: 25 September 2019

Vote: For 51, Against 15, Abstentions 5 Link

Vote in Plenary: 10 October 2019

Vote: For 436, Against 208, Abstentions 16

Votewatch link

 

Commission’s follow up:

2019:2830-3

 

4.

Objection to GMO Soybean

Implementing Act

Co-Rapporteurs: Sirpa Pietikäinen (PPE), Günther Sidl (S&D), Nicolae Ştefănuță (Renew), Tilly Metz (Verts/ALE), Anja Hazekamp (GUE/NGL), Eleonora Evi (NI)

Debate in Committee: 25 September 2019

Vote: For 50, Against 14, Abstentions 7 Link

Vote in Plenary: 10 October 2019

Vote: For 426, Against 208, Abstentions 20

Votewatch link

See above debate

Commission’s follow up:

 

4-2019:2828

5.

Objection to GMO Maize

Implementing Act

Co-Rapporteurs: Sirpa Pietikäinen (PPE), Günther Sidl (S&D), Nicolae Ştefănuță (Renew), Tilly Metz (Verts/ALE), Anja Hazekamp (GUE/NGL), Eleonora Evi (NI)

Debate in Committee: 25 September 2019

Vote: For 50, Against 16 Abstentions 4 Link

Vote in Plenary: 10 October 2019

Vote: For 435, Against 207, Abstentions 18

Votewatch link

See debate above

 

Commission’s follow up:

5.2019:2829

6.

Objection on the assessment of the impact of plant protection products on honeybees

RPS

Co-Rapporteurs: Eric Andrieu (S&D), Martin Hojsík (Renew), Bas Eickhout (Verts/ALE), Anja Hazekamp (GUE/NGL)

Debate in Committee: 21 October 2019

Vote: For 62, Against 4, Abstentions 7 Link

Vote in Plenary: 23 October 2019

Vote: For 533, Against 67, Abstentions 100

Votewatch link

 

 

Commission’s follow up:

2019:2776

Objection to the authorization for a use of chromium trioxide – Cromomed

Implementing Act

Co-Rapporteurs: Maria Arena (S&D), Martin Hojsík (Renew), Bas Eickhout (Verts/ALE)

Debate in Committee: 21 October

Vote: For 43, Against 28, Abstentions 1 Link

Vote in Plenary: 24 October 2019

Vote: For 301, Against 295, Abstentions 45

Votewatch link

 

 

Commission’s follow up:

 

7.2019:2844

8.

Objection  pursuant to authorization GMO cotton LLCotton25

Implementing Act

Co-Rapporteurs: Günther Sidl (S&D), Tilly Metz (Verts/ALE), Anja Hazekamp (GUE/NGL), Eleonora Evi (NI), Sirpa Pietikäinen

Debate in Committee: 6 November 2019

Vote: For 46, Against 25, Abstentions: 0  Link

Vote in Plenary: 14 November 2018

Vote: For 448, Against 189, Abstentions 28

Votewatch link

 

Commission’s follow up:

8.2019:2856

9.

Objection to GMO soya 89788

Implementing Act

Co-Rapporteurs: Günther Sidl (S&D), Tilly Metz (Verts/ALE), Anja Hazekamp (GUE/NGL), Eleonora Evi (NI), Sirpa Pietikäinen

Debate in Committee: 6 November 2019

Vote: For 47, Against 25, Abstention 0  Link

Vote in Plenary: 14 November 2019

Vote: For 448, Against 186, Abstentions 30

Votewatch link

Commission’s follow up:

9.2019:2857

10.

Objection pursuant to the authorization of GMO maize MON 89034

Implementing Act

Co-Rapporteurs: Sirpa Pietikäinen, Günther Sidl (S&D),Nicolae Ştefănuță (Renew) Tilly Metz (Verts/ALE),  Anja Hazekamp (GUE/NGL), Eleonora Evi (NI)

Debate in Committee: 6 November 2019

Vote: For 46, Against 24, Abstention 0  Link

Vote in Plenary: 14 November 2019

Vote: Vote: For 465, Against 169, Abstentions 30

Votewatch link

 

Commission’s follow up:

 

10.2019:2859

11.

Objection to the authorization of GMO maize Bt11

Implementing Act

Co-Rapporteurs: Günther Sidl (S&D), Tilly Metz (Verts/ALE), Anja Hazekamp (GUE/NGL), Eleonora Evi (NI), Sirpa Pietikäinen

Debate in Committee: 6 November 2019

Vote: For 51, Against 21, Abstention 0  Link

Vote in Plenary: 14 November

Vote: For 467, Against 171, Abstentions 27

Votewatch link

 

Commission’s follow up:

11.2019:2860

 

 

12.

Objection to Delegated act on classification, labeling, and packaging of substances and mixtures – titanium dioxide

Delegated Act

Rapporteur: Anna Zalewska (ECR)

Debate in Committee: 2 December 2019

Vote: For 19, Against 47, Abstentions 4  Link

 

13.

Objection to Imports of Pet Food from Saudi-Arabia

Implementing Act

Rapporteur: Joëlle Mélin (ID)

Debate in Committee: 2 December 2019

Vote: For 12, Against 58, Abstentions 1  Link

14.

Objection to the import of food from Japan

Implementing Act

Rapporteurs: Michèle Rivasi (Verts/ALE) Sirpa Pietikäinen

Debate in Committee: 2 December 2019

Vote: For 30, Against 40, Abstentions 1  Link

15.

Objection to the extension of the active substances benfluralin and others

Implementing Act

Rapporteurs: Tilly Metz (Verts/ALE), Anja Hazekamp (GUE/NGL), Eleonora Evi (NI

Debate in Committee: 2 December 2019

Vote: For 44, Against 27, Abstentions 0  Link

Vote in Plenary: 18 December 2019

Vote: For 443, Against 216, Abstentions 33

Votewatch link

Commission’s follow up:

benfluralin

16.

Objection to REACH Restriction lead in PVC

RPS

Co- Rapporteurs: Bas Eickhout (Verts/ALE) Maria Arena (S&D) Martin Hojsík (Renew)

Debate in Committee: 21 January 2020

Vote: For 42, Against 22, Abstentions 4  Link

Vote in Plenary: 12 February 2020

Vote: For 394, Against 241, Abstentions 13

Votewatch link (note not on the Resolution as a whole – not listed)

Commission’s follow up:

16

17.

Objection to the non-approval of propolis extract

Implementing Act

Rapporteur: Joëlle Mélin (ID)

Debate in Committee: 3 February 2020

Vote: For 7, Against 59, Abstentions 5  Link

17

18.

Objection to authorizing GMO soybean 87708

Implementing Act

Co-Rapporteurs: Tilly Metz (Verts/ALE), Günther Sidl (S&D)Anja Hazekamp (GUE/NGL), Sirpa Pietikäinen (PPE),Eleonora Evi (NI)

Debate in Committee: 3 February 2020

Vote: For 48, Against 22, Abstentions 0  Link

Vote in Plenary: 13 May 2020

Vote: For 477, Against 181, Abstentions 23

Votewatch link

 

18

19.

Objection to maximum residue levels for cycloxydim and others

RPS

Rapporteur: Michèle Rivasi (Greens/EFA)

Debate in Committee: 21 April 2020

Vote: For 45 Against 32, Abstentions 4  Link

Vote in Plenary: 17 September 2020

Vote: For 372, Against 275, Abstentions 39

Vote watch link

MRLcycloxydim

20.

Objection to renewing the approval of the active substance pyriproxyfen

Implementing Act

Rapporteur: Joëlle Mélin (ID)

Debate in Committee: 28 May 2020

Vote: For 12, Against 51, Abstentions 11  Link

21.

Objection to authorisation  to REACHLaw Ltd for certain uses of chromium trioxide

Implementing Act

Co-Rapporteurs: Bas Eickhout (Verts/ALE) Maria Arena (S&D) Martin Hojsík (Renew)

Debate in Committee: 8 June 2020

Vote: For 38, Against 35, Abstentions 3  Link

Vote in Plenary: 10 July 2020

Vote: For: 325, Against 325, Abstentions 35

Votewatch link

 

22.

Objection to the extension of the approval periods of the active substances beflubutamid and others

Implementing Act

Co-Rapporteurs: Anja Hazekamp (GUE/NGL), Maria Arena (S&D), Tilly Metz (Verts/ALE), Eleonora Evi (NI)

Debate in Committee: 8 June 2020

Vote: For 43, Against 30, Abstentions 3   Link

Vote in Plenary: 10 July 2020

Vote: For: 415, Against 252, Abstentions 20

Votewatch link

 

22

23.

Objection for food additives  specifications for titanium dioxide (E 171)

RPS

Co-Rapporteurs: Michèle Rivasi, Eric Andrieu, Eleonora Evi, Joëlle Mélin, Ljudmila Novak, Mick Wallace

Debate in Committee: 7 September 2020

Vote: For 51, Against 11, Abstentions 16   Link

Vote in Plenary: 7 October 2020

Vote: For: 443, Against 118, Abstentions 135

Votewatch link

 

23

24

Objection to maximum levels of acrylamide in certain foodstuffs for infants and young children

RPS

Co-Rapporteurs: Jutta Paulus, Christel Schaldemose, Martin Hojsík, Eleonora Evi, Sirpa Pietikäinen, Mick Wallace

Debate in Committee: 28 September 2020

Vote: For 51, Against 11, Abstentions 16  Link

Vote in Plenary: 7 October 2020

Vote: For: 469, Against 137, Abstentions 90

Votewatch link

 

 

24

25.

Objection to Restriction on lead shot

RPS

Co-Rapporteurs: Alexander Bernhuber, Ondřej Knotek, Andrey Slabakov

Debate in Committee: 29 October 2020

Vote: For 33, Against 42, Abstentions 4  Link

Vote in Plenary: 24 November 2020

Vote: For: 292, Against 362, Abstentions 39

Votewatch link

26.

Objection to GMO soya SYHT0H2

Implementing Act

Co-Rapporteurs: Tilly Metz, Günther Sidl, Anja Hazekamp, Eleonora Evi, Sirpa Pietikäinen

Debate in Committee: 29 October 2020

Vote: For 51, Against 26, Abstentions 3  Link

Vote in Plenary: 11 November 2020

Vote: For: 476, Against 178, Abstentions 25

Votewatch link

27.

Objection to GMO maize MON 87427

Implementing Act

Co-Rapporteurs: Tilly Metz, Günther Sidl, Anja Hazekamp, Eleonora Evi, Sirpa Pietikäinen

Debate in Committee: 29 October 2020

Vote: For 52, Against 25, Abstentions 3  Link

Vote in Plenary: 11 November 2020

Vote: For: 483, Against 178, Abstentions 25

Votewatch link

 

See debate above

 

28.

Objection to GMO maize

Implementing Act

Co-Rapporteurs: Tilly Metz, Günther Sidl, Anja Hazekamp, Eleonora Evi, Sirpa Pietikäinen

Debate in Committee: 29 October 2020

Vote: For 57, Against 21, Abstentions 2  Link

Vote in Plenary: 11 November 2020

Vote: For 526, Against 142, Abstentions 18

Votewatch link

 

See debate above

29.

Objection to approving carbendazim as an active substance in biocidal products

Implementing Act

Co-Rapporteurs: Maria Arena, Michèle Rivasi, Anja Hazekamp, Eleonora Evi

Debate in Committee: 16 November 2020

Vote: For 48, Against 26, Abstentions 3  Link

Vote in Plenary: 25 November 2020

Vote: For: 458, Against 219, Abstentions 19

Votewatch ink

 

30.

Objection to the extension of the active substances chlorotoluron,and others

Implementing Act

Co-Rapporteurs: Anja Hazekamp, Maria Arena, Tilly Metz, Eleonora Evi

Debate in Committee: 16 November 2020

Vote: For 45, Against 28, Abstentions 4  Link

Vote in Plenary: 25 November 2020

Vote: For: 425, Against 231, Abstentions 40

Votewatch link

31.

Objection to GMO soy bean MON 87751

Implementing Act

Co-Rapporteurs: Tilly Metz (Verts/ALE), Günther Sidl (S&D), Anja Hazekamp (GUE/NGL), Eleonora Evi (NI), Sirpa Pietikäinen (PPE)

Vote in Committee:30 November 2020

Vote: For 50, Against 27, Abstentions 3  Link

Vote in Plenary: 17 December 2020

Vote: For: 472, Against 194, Abstentions 30

Votewatch link

32.

Objection to genetically modified maize 87427 

Implementing Act

Co-Rapporteurs: Tilly Metz (Verts/ALE), Günther Sidl (S&D), Anja Hazekamp (GUE/NGL), Eleonora Evi (NI), Sirpa Pietikäinen (PPE)

Debate in Committee:30 November 2020

Vote: For 53, Against 21, Abstentions 1  Link

Vote in Plenary: 17 December 2020

Vote: For: 488, Against 186, Abstentions 22

Votewatch link

33.

Objection to genetically modified maize  MON 89034

Implementing Act

Co-Rapporteurs: Tilly Metz (Verts/ALE), Günther Sidl (S&D), Anja Hazekamp (GUE/NGL), Eleonora Evi (NI), Sirpa Pietikäinen (PPE)

Debate  in Committee:  30 November 2020

Vote: For 53, Against 26, Abstentions 1  Link

Vote in Plenary:17 December 2020

Vote: for 488, against 186, abstentions: 22

Votewatch link

34.

Objection to genetically modified maize MIR604 (renewal)

Implementing Act

Co-Rapporteurs: Tilly Metz (Verts/ALE), Günther Sidl (S&D), Anja Hazekamp (GUE/NGL), Eleonora Evi (NI), Sirpa Pietikäinen (PPE)

Debate  in Committee: 30 November 2020

Vote: For 53, Against 26, Abstentions 1  Link

Vote in Plenary: 17 December 2020

For: 489, Against 185, Abstensions: 22

Votewatch link

35.
Genetically modified soybean MON 87751 × MON 87701 × MON 87708 × MON 89788

Implementing Act

Co-Rapporteurs: Tilly Metz (Verts/ALE), Günther Sidl (S&D), Anja Hazekamp (GUE/NGL), Eleonora Evi (NI), Sirpa Pietikäinen (PPE)

Debate in Committee: 30 November 2020

Vote: For 50, Against 27, Abstentions 3

Vote in Plenary: 17 December 2020

Vote: 472, Against 194, Abstentions 30

Votewatch link

 

36.

Objection to GMO maize 89034

Implementing Act

Co-Rapporteurs: Tilly Metz (Verts/ALE), Günther Sidl (S&D), Anja Hazekamp (GUE/NGL), Eleonora Evi (NI), Sirpa Pietikäinen (PPE)

Debate in Committee: 30 November 2020

Vote: For 50, Against 27, Abstentions 3  Link

Vote in Plenary: 17 December 2020

Vote: 472, Against 194, Abstentions 30

 

 

37.

30 November 2020 –

Early non-objection pursuant to Rule 112(4)(d) and Rule 111 (6): Postponement of the latest application date set for the substance group 4-(1,1,3,3-Tetramethylbutyl)phenol, ethoxylated with regard to specific uses linked to COVID-19

Implementing Act

Rapporteur: Pascal Canfin

Link  Minutes

Vote: For 75, Against 1, Abstentions 4

 

38.

Objection to MRLs for aclonifen and others

RPS

Rapporteur: Joëlle Mélin

Debate  in Committee: 10 December 2020

Vote: For 9, Against 57, Abstentions 13  Link

 

 

39.

Objection to MRLs for carbon tetrachloride

RPS

Rapporteur: Joëlle Mélin

Debate in Committee: 10 December 2020

Vote: For 10, Against 65, Abstentions 5  Link

See debate above

40.

Objection to MRLs for fluxapyroxad

RPS

Rapporteur: Joëlle Mélin

Debate in Committee: 10 December 2020

Vote: For 9, Against 70, Abstentions 0  Link

 

Rapporteur: Sergio Berlato (ECR)
Debate in Committee: 14 January
Adopted: For 17; against: 55; abstention(s): 7  Link

 

42.

Objection to non-approval of cayenne extract

Implementing Act

Rapporteur: Joëlle Mélin

Debate in Committee: 26 January 2021

Vote: For 9, Against 70, Abstentions 0  Link

43

Implementing Act (LULUCF Regulation)
Delegated Act
Rapporteur: Nils Torvalds (Renew
Debate in Committee:  26 January 2021
Vote: For 16; against: 60; abstention(s): 2  Link

 

 

44

Objection pursuant to Rule 112(2) and (3) on the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin

Implementing Act

Rapporteurs: Anja Hazekamp, Maria Arena, Tilly Metz

Vote in Committee: 24 February 2021

Vote: For 49, Against 29, Abstention 1  Link

Vote in Plenary: 10 March 2021

Vote for 472, Against 214, Abstentions 9

Voewatch link

 

 

45

Objection pursuant to Rule 112(2) and (3) on the placing on the market of products containing, consisting of or produced from genetically modified cotton GHB614 × T304-40 × GHB119

Implementing Act

Rapporteurs: Martin Häusling, Günther Sidl, Anja Hazekamp, Sirpa Pietikäinen

Vote in Committee: 25 February 2021

Votes: For 53, Against 25, Abstention 1  Link

Vote in Plenary: 10 March 2021

Votes: For 491, Against 184, Abstentions 20

Votewatch link

46

Objection pursuant to Rule 112(2) and (3) on the placing on the market of products containing, consisting of or produced from genetically modified maize MZIR098 (SYN-ØØØ98-3)

Implementing Act

Rapporteurs:Martin Häusling, Günther Sidl, Anja Hazekamp, Sirpa Pietikäinen

Vote in Committee: 25 February 2021
Vote: For 54, Against 25, Abstention 1  Link
Vote in Plenary: 10 March 2021
Votes: For 495, Against 181, Abstentions 19
Votewatch link
47
Objection on the draft Commission regulation amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for aclonifen, acrinathrin, Bacillus pumilus QST 2808, chlorantraniliprole, ethirimol, lufenuron, penthiopyrad, picloram and Pseudomonas sp. strain DSMZ 13134 in or on certain products
RPS Measure
Rapporteurs: Jutta Paulus, Sirpa Pietikäinen, Christel Schaldemose, Mick Wallace
Vote in Committee: 15 April 2021
Note: Joelle Melin’s separate  challenge to the same act (for a different substance chlorantraniliprole) fell when  Paulus challenge was adopted.
Vote: For 48, Against 32
Voting Results link.
Vote in Plenary: 27 April  2021
Votes: For 441, Against 242, Abstentions 15
48

 

49. Objection to draft Commission Implementing Regulation amending Regulation (EU) No 37-2010 to classify the substance  imidacloprid as regards its maximum residue limit in foodstuffs of animal origin

RPS Measure

Objectors: Grace O’Sullivan (Greens/EFA)

Vote in Committee: 27 May 2021

Vote:  For 49, Against 27, Abstain 2

Plenary 9 June 2021

Vote: For 441, Against 232, Abstain 18

50.Objection to Commission Implementing Regulation (EU) amending Implementing Regulation(EU) 540-2011as regards the extension of the approval periods ofseveral active substances, including flumioxazine

Implementing Act

Objectors: AnjaHazekamp (TheLeft),MariaArena(S&D), Tilly Metz (Greens/EFA)

Vote in Committee: 27 May 2021

Vote:  For 49, Against 27, Abstain 2

Plenary 9 June 2021

Vote: 434, Against 230, Abstain 27

 

51. Objection pursuant to Rule 112(2) and (3): authorising the placing on the market of products containing, consisting of or produced from genetically modified soybean DAS- 81419-2 pursuant to Regulation(EC) No 1829/2003ofthe European Parliament and of the Council –

Co-rapporteurs: Martin Häusling (Verts/ALE), Günther Sidl (S&D), Anja Hazekamp (The Left), Sirpa Pietikäinen (PPE))

Implementing act

Vote: 21 June

Vote: For 48, Against 28, Abstentions 3

Vote in Plenary: 6 July 2021

Vote For 470, Against 199, Abstentions 23

52. Objection pursuant to Rule 112(2) and (3): authorising the placing on the market of products containing, consisting of or produced from genetically modified soybean DAS- 81419-2 × DAS–44406–6, pursuant to Regulation (EC) No 1829/2003 of the European

Co-rapporteurs: Martin Häusling (Verts/ALE), Günther Sidl (S&D), Anja Hazekamp (The Left), Sirpa Pietikäinen (PPE)

Implementing act

Vote: 21 June 2021

Vote: For 49, Against 27, Abstentions 3

Vote in Plenary: 6 July 2021

Vote For 470, Against 199, Abstentions 23

1234185EN

53. Objection pursuant to Rule 112(2) and (3): authorising the placing on the market of products containing, consisting of or produced from genetically modified maize 1507 × MIR162 × MON810 × NK603 and genetically modified maize combining two or three of the single events 1507, MIR162, MON810 and NK603, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council – 1234186ENv2

Co-rapporteurs: Martin Häusling (Verts/ALE), Günther Sidl (S&D), Anja Hazekamp (The Left), Sirpa Pietikäinen (PPE)

Implementing act

Vote: 21 June 2021

Vote: For 49, Against 27, Abstentions 3

Vote in Plenary: 6 July 2021

Vote For 470, Against 200, Abstentions 22

Votewatch link

54.  Objection pursuant to Rule 112(2) and (3): renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified maize Bt 11 (SYN-BTØ11-1) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council –1234187Bt11

Co-rapporteurs: Martin Häusling (Verts/ALE), Günther Sidl (S&D), Anja Hazekamp (The Left), Sirpa Pietikäinen (PPE)

Implementing act

Vote: 21 June 2021

Vote: For 49, Against 28, Abstentions 2

Vote in Plenary: 6 July 2021

Vote For 470, Against 200, Abstentions 22

 

 

55. Commission Regulation amending Annex IV to Regulation (EC) No 999/2001 of the European Parliament and of the Council as regards the prohibition to feed non-ruminant farmed animals, other than fur animals, with protein derived from animals (RE_Objection_RPS_animals_proteins_EN)

Co- rapporteurs: Piernicola Pedicini (Verts/ALE), Anja Hazekamp (The Left))

Implementing act

Vote: 21 June 2021

Vote: For 35, Against 39, Abstentions 5

 

56. Objection on the Commission delegated regulation of 26 May 2021 supplementing Regulation (EU) 2019/6 of the European Parliament and of the Council by establishing the criteria for the designation of antimicrobials to be reserved for the treatment of certain infections in humans (link)

Rapporteurs: Martin Häusling (Verts/ALE)

Delegated act

Vote: 12 July 2021

Vote: For 38, Against 18, Abstentions 22

Vote in Plenary: 15 September July 2021

Vote For 204, Against 450, Abstentions 32

 

Votewatch Link

57. Objection pursuant to Rule 112(2) and (3) to Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances, including chlorotoluron and difenoconazole (link)

Rapporteurs: Anja Hazekamp, Maria Arena, Tilly Metz

Implementing act

Date: 27 September 2021

Vote: For 47, Against 30, Abstentions 0

Vote in Plenary:5 October 2021

Vote For 407, Against 256, Abstentions 24

 

Votewatch link

 

58. Commission Delegated Regulation supplementing Regulation (EU) 2020/852 of the European Parliament and of the Council by establishing the technical screening criteria for determining the conditions under which an economic activity qualifies as contributing substantially to climate change mitigation or climate change adaptation and for determining whether that economic activity causes no significant harm to any of the other environmental objectives- Joint ECON-ENVI (CJ36) (link)

Rapporteurs: Nicola Beer, Jessica Polfjärd, Andreas Glück, Emma Wiesner

Delegated act

Vote: 27 September 2021

Vote: For 34, Against 92, Abstentions 4

Vote in Plenary: 5 October 2021

Vote: For 227, Against 428, Abstentions 31

 

 

Votewatch link

 

 

59.  Objection pursuant to Rule 112(2) and (3) and (4)(c) of the Rules of Procedure on the draft Commission regulation amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for flonicamid in or on certain products (link)

Rapporteurs: Michèle Rivasi (Greens/EFA

Implementing act

Vote: 6 December 2021

Vote: For 16, Against 53, Abstentions 5 (Link)

 

  1. Objection pursuant to Rule 112(2) and (3) : Authorising the placing on the market of products containing, consisting of or produced from genetically modified soybean

Rapporteurs:  Martin Häusling (Verts/ALE), Günther Sidl (S&D), Anja Hazekamp (The Left), Sirpa Pietikäinen (EPP)

Implementing act

Vote: 13 January 2022

Vote: For 45, Against 31, Abstentions 2 (link)

Vote in Plenary: 15 February 2022

Vote: For 475, Against  209,  Abstenstions 15

  1.  Objection pursuant to Rule 112(2) and (3) renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified cotton

Rapporteurs: Martin Häusling (Verts/ALE), Günther Sidl (S&D), Anja Hazekamp (The Left), Sirpa Pietikäinen (PPE)

Implementing act

Vote: 13 January 2022

Vote: For 45, Against 31, Abstentions 2 (link)

Vote in Plenary: 15 February 2022

Vote: For 477, Against 207, Abstentions 15

  1. COVID-19 mRNA

Rapporteurs: Sylvia Limmer (ID)

Implementing act

Vote: 10 February 2022

Vote: For 9, Against 71, Abstentions 2 (link)

 

  1.  Genetically modified cotton GHB811 (BCS-GH811-4)

Co-rapporteurs: Martin Häusling (Verts/ALE), Anja Hazekamp (The Left), Sirpa Pie tikäinen (PPE), Günther Sidl (S&D)

Implementing act

Vote: 10 February 20022

Vote: For 56, Against 29, Abstentions 2 (link)

Vote in Plenary: 9 March 2022

Vote: For 428, Against 198, Abstentions 14

  1. .genetically modified oilseed rape 73496

Co-rapporteurs: Martin Häusling (Verts/ALE), Anja Hazekamp (The Left), Sirpa Pietikäinen (PPE), Günther Sidl (S&D)

Implementing act

Vote: 10 February 20022

 Vote: For 56, Against 29, Abstentions 2 (link)

Vote in Plenary 9 March 2022

Vote: For 474, Against 205, Abstentions 15

  1. Draft Commission regulation amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for flutianil in or on certain products

Co-rapporteurs: Jutta Paulus (Verts/ALE), Maria Arena (S&D), Sirpa Pietikäinen (PPE), Mick Wallace (The Left))

RPS

Vote: 15 March 20022

Vote: For 47, Against 38, Abstentions 1 (link)

Vote in Plenary 24 March 2022

Vote: Rejected

  1.  Objection to IA authorising the placing on the market of products containing, consisting of or produced from genetically modified soybean MON 87769 x MON 89788

 Co-rapporteurs: Martin Häusling (Greens/EFA), Anja Hazekamp (The Left), Sirpa Pietikäinen (EPP), Günther Sidl (S&D))

Implementing act

Vote: 31 March 2022

Vote: For 53, Against 31, Abstentions 1 (link)

Vote in Plenary: 6 April 2022

Vote: For 420, Against 189, Abstentions 16

  1. Objection pursuant to Rule 112(2) and (3) to the Commission Implementing Decision on the annual renewal of the conditional marketing authorisation for the medicinal product for human use “Veklury – remdesivir”

 Adoption of motion for a resolution tabled by Michèle Rivasi (Verts/ALE) In favour 23

Date: 14 June 2022

Votes: For 23, Against 56, Abstention 1

 Adoption of motion for a resolution tabled by Joëlle Mélin (ID)

Implementing act

Date: 14 June 2022

Votes: For 6, Against 70, Abstentions 3

  1. Objection pursuant to Rule 112(2) and (3): authorising the placing on the market of products containing, consisting of or produced from genetically modified maize NK603 × T25 × DAS-40278-9 and its sub- combination T25 × DAS-40278-9,

Co-Rapporteurs:  Martin Häusling (Greens/EFA), Anja Hazekamp (The Left), Sirpa Pietikäinen (EPP), Günther Sidl (S&D)

Implementing act

Vote: 14 June 2022

Vote: For 53, Against 26, In favour 53, Abstention 1

  1. Objection pursuant to Rule 112(2) and (3): authorising the placing on the market of products containing, consisting of or produced from genetically modified maize DP4114 × MON 810 × MIR604 × NK603 and genetically modified maize combining two or three of t

 Co-Rapporteurs: Martin Häusling (Greens/EFA), Anja Hazekamp (The Left), Sirpa Pietikäinen (EPP), Günther Sidl (S&D)

Implementing act

Vote: 13 June

Vote: For 52, Against 27, Abstention 1

  1. Objection pursuant to Rule 112(2) and (3) designating antimicrobials or groups of antimicrobials reserved for treatment of certain infections in humans, in accordance with Regulation (EU) 2019/6 of the European Parliament and of the Council

Co-rapporteur:  Martin Häusling (Greens/EFA), Tiemo Wölken (S&D), Nicolae Ştefănuță (Renew), Anja Hazekamp (The Left)

Implementing act

Vote: 13 June

Vote: For 48, Against 27, Abstention

Vote in Plenary: Date

Vote:

  1. Objection to Commission Delegated Regulation amending Delegated Regulation (EU) 2021/2139 as regards economic activities in certain energy sectors and Delegated Regulation (EU) 2021/2178 as regards specific public disclosures for those economic activities

 Joint committee procedure (Rule 58) Committee on Economic and Monetary Affairs and Committee on the Environment, Public Health and Food Safety

Co-rapporteurs: : Othmar Karas, Christophe Hansen, Alexander Bernhuber, Sirpa Pietikäinen, Paul Tang, Simona Bonafè, Martin Hojsík, Linea Søgaard-Lidell, Emma Wiesner, Monica Semedo, Claudia Gamon, Róża Thun und Hohenstein, Bas Eickhout and Michael Bloss (on behalf of the Greens/EFA), Silvia Modig and Dimitrios Papadimoulis (on behalf of the LEFT), Evelyn Regner, Rasmus Andresen, Jutta Paulus, Marie Toussaint, Roman Haider, Mick Wallace, Nikolaj Villumsen, Anja Hazekamp, Cornelia Ernst, Malin Björk, José Gusmão, Marisa Matias, Idoia Villanueva Ruiz, Martin Schirdewan, Chris MacManus, Manon Aubry, Manuel Bompard, Petros Kokkalis

Delegated act

14 June

Vote: For 76, Against 62, Abstention 4

Vote in Plenary: 6 July 2022

Votes: For 278, Against 328, Abstentions 33